Overview
John Ferrante is a primary care provider, practicing in Internal Medicine in Methuen, Massachusetts. Dr. Ferrante is rated as an Experienced provider by MediFind in the treatment of Glycine Encephalopathy. His top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, Hypertension, and High Cholesterol. Dr. Ferrante is currently accepting new patients.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
60 E St, 2200 Revere Medical Primar, Methuen, MA 01844
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Eric Guardino is a primary care provider, practicing in Internal Medicine in Lexington, Massachusetts. Dr. Guardino is rated as an Experienced provider by MediFind in the treatment of Glycine Encephalopathy. His top areas of expertise are Glycine Encephalopathy, Necrotizing Vasculitis, Chronic Cough, and Inborn Amino Acid Metabolism Disorder.
Concord Hospital Inc
Paul Clark is a primary care provider, practicing in Internal Medicine in Concord, New Hampshire. Dr. Clark is rated as an Experienced provider by MediFind in the treatment of Glycine Encephalopathy. His top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Hypertension, Familial Hypertension, and Claw Foot.
Maria Rodrigues is a primary care provider, practicing in Internal Medicine in Randolph, Massachusetts. Dr. Rodrigues is rated as an Experienced provider by MediFind in the treatment of Glycine Encephalopathy. Her top areas of expertise are Endocarditis, Hypertension, Familial Hypertension, and Glucocorticoid-Remediable Aldosteronism. Dr. Rodrigues is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Familial HypertensionDr. Ferrante isAdvanced. Learn about Familial Hypertension.
- Glucocorticoid-Remediable Aldosteronism
- HypertensionDr. Ferrante isAdvanced. Learn about Hypertension.
- Experienced
- AnemiaDr. Ferrante isExperienced. Learn about Anemia.
- AsthmaDr. Ferrante isExperienced. Learn about Asthma.
- Asthma in ChildrenDr. Ferrante isExperienced. Learn about Asthma in Children.
- AtherosclerosisDr. Ferrante isExperienced. Learn about Atherosclerosis.
- Autoerythrocyte SensitivityDr. Ferrante isExperienced. Learn about Autoerythrocyte Sensitivity.
- Chronic Obstructive Pulmonary Disease (COPD)